About this article Cite this article Katsurada, K., Nandi, S.S., Zheng, H
March 19, 2026 Positive topline results reported from the phase 3 TRANSCEND-T2D-1 trial Retatrutide met the primary and all key secondary endpoints at 40 weeks in adults diagnosed with type 2 diabetes with inadequate glycemic control with diet and exercise alone and a mean duration of diabetes of 2.5 years
For patients who are unsure if GLP-1s are right for them, that lack of flexibility can make Hers feel like a gamble
But thats just the first step in treatment
Reduced roGFP2 was oxidized much faster by GSSG in the presence of AtGrxS15 as compared with a negative control (Supplementary Fig
KPV (Lys-Pro-Val, 10mg) is the C-terminal tripeptide fragment of alpha-MSH, characterized for competitive inhibition of NF-B nuclear translocation via importin-3 binding at nanomolar concentrations the mechanistic pathway that distinguishes KLOW from the three-component GLOW blend